300 patients, advocates and researchers talk science, health disparities and filling in crucial data gaps at 'mets' conference
Sept. 26, 2017
| By Diane Mapes / Fred Hutch News Service
More than 300 metastatic breast cancer patients, researchers, advocates and caregivers gathered in Seattle over the weekend to discuss promising new therapies, patient-researcher partnerships, big data, advocacy, and, yes, cures.
SCCA study findings have implications for personalized breast cancer treatment and drug development
Aug. 29, 2011
| By Dean Forbes
For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.
Linden and colleagues find PET scans can provide accurate, early assessment of response to breast-cancer therapy
June 1, 2009
| By Dean Forbes
Dr. Hannah Linden of the Seattle Cancer Care Alliance and colleagues discovered the response of patient's with estrogen receptor positive breast cancer to standard aromatase-inhibitor therapy can be measured by noninvasive imaging with similar results to invasive needle sampling.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.